Bernard Lam is Vice President, Finance of Notch Therapeutics. Mr. Lam joined Notch with more than 20 years of experience in the biopharmaceutical industry. Prior to Notch, he served as Interim Senior Director, Finance at Neoleukin Therapeutics following its merger in 2019 with Aquinox Pharmaceuticals. Previously, in his role as Senior Director, Finance at Aquinox, he provided finance leadership in the company’s transition to a publicly traded company. Prior to Aquinox, Mr. Lam was Vice President, Finance at Viable Healthworks and held senior finance roles at Allon Therapeutics and QLT, Inc. Mr. Lam is a Chartered Professional Accountant and holds a B.B.A. from Simon Fraser University.

• 

  Vice President, Finance in Notch Therapeutics

  Notch is building best-in-class T cell therapies.